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Abstract
Background: Carbohydrate restricted diets (CRD) consistently lower glucose and insulin levels and
improve atherogenic dyslipidemia [decreasing triglycerides and increasing HDL cholesterol (HDL-C)]. We
have previously shown that male subjects following a CRD experienced significant increases in HDL-C only
if they were consuming a higher intake of cholesterol provided by eggs compared to those individuals who
were taking lower concentrations of dietary cholesterol. Here, as a follow up of our previous study, we
examined the effects of eggs (a source of both dietary cholesterol and lutein) on adiponectin, a marker of
insulin sensitivity, and on inflammatory markers in the context of a CRD.
Methods: Twenty eight overweight men [body mass index (BMI) 26–37 kg/m2] aged 40–70 y consumed
an ad libitum CRD (% energy from CHO:fat:protein = 17:57:26) for 12 wk. Subjects were matched by age
and BMI and randomly assigned to consume eggs (EGG, n = 15) (640 mg additional cholesterol/day
provided by eggs) or placebo (SUB, n = 13) (no additional dietary cholesterol). Fasting blood samples were
drawn before and after the intervention to assess plasma lipids, insulin, adiponectin and markers of
inflammation including C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α), interleukin-8 (IL-
8), monocyte chemoattractant protein-1 (MCP-1), intercellular adhesion molecule-1 (ICAM-1), and
vascular cell adhesion molecule-1(VCAM-1).
Results: Body weight, percent total body fat and trunk fat were reduced for all subjects after 12 wk (P <
0.0001). Increases in adiponectin were also observed (P < 0.01). Subjects in the EGG group had a 21%
increase in this adipokine compared to a 7% increase in the SUB group (P < 0.05). Plasma CRP was
significantly decreased only in the EGG group (P < 0.05). MCP-1 levels were decreased for the SUB group
(P < 0.001), but unchanged in the EGG group. VCAM-1, ICAM-1, TNF-α, and IL-8 were not modified by
CRD or eggs.
Conclusion: A CRD with daily intake of eggs decreased plasma CRP and increased plasma adiponectin
compared to a CRD without eggs. These findings indicate that eggs make a significant contribution to the
anti-inflammatory effects of CRD, possibly due to the presence of cholesterol, which increases HDL-C and
to the antioxidant lutein which modulates certain inflammatory responses.
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Background
Insulin resistance is recognized as the major defect leading
to the development of the metabolic syndrome including
a proinflammatory state. Experimental and epidemiolog-
ical evidence reveals that chronic inflammation is an inde-
pendent predictor of cardiovascular disease (CVD) [1]
and is directly involved in the promotion of insulin resist-
ance and atherosclerosis [2-4]. Infections or the healing of
wounds produce an inflammatory response which attracts
leukocytes to a localized area of the vasculature and per-
mits passage through the underlying tissue [5]. Repeated
stimulation of this inflammatory response can lead to the
development of several chronic diseases mediated by
increased levels of cytokines and chemokines. Adipose tis-
sue secretes several adipokines, such as tumor necrosis
factor-alpha (TNF-α), interleukin-8 (IL-8), and adiponec-
tin which can modulate lipid and glucose metabolism [6].
Adiponectin is a unique hormone that is both anti-
inflammatory and anti-atherogenic and low circulating
levels are found in obese, insulin resistant individuals.
Elevated levels of the acute-phase reactant C-reactive pro-
tein (CRP) and TNF-α are associated with an increased
risk for numerous chronic diseases [7]. Monocyte chem-
oattractant protein-1 (MCP-1) is a proinflammatory
chemokine produced in response to inflammatory stimuli
like TNF-α. Additionally, upregulation of vascular cell
adhesion molecule-1 (VCAM-1) and intercellular adhe-
sion molecule-1 (ICAM-1) signifies the initiation of
atherogenesis by permitting circulating cells to adhere to
the endothelium [8-10].
Acute carbohydrate consumption has been shown to
stimulate reactive oxidative species while initiating many
pro-inflammatory processes [11]. Additionally, isocaloric
high carbohydrate diets are associated with several mark-
ers of inflammation [12]. Carbohydrate restricted diets
(CRD) are able to reduce biomarkers of inflammation in
the absence of weight loss [13,14]. Dietary carbohydrate,
rather than fat, plays a critical role in activating pro-
inflammatory processes through their effect on the fatty
acid composition of lipids and membranes [15]. Endog-
enous fatty acids function as ligands for receptors and
transcription factors that modulate inflammatory signal-
ing cascades. CRDs are ideal for reducing inflammation
because they reduce plasma glucose excursions, the major
stimulus for pancreatic secretion of insulin, and modulate
the underlying factors associated with CVD and the meta-
bolic syndrome.
Eggs are a breakfast staple that are affordable and provide
a good source of protein and other valuable nutrients.
Experimental studies show that the additional dietary
cholesterol provided by whole eggs does not increase the
risk of CVD in a variety of sample populations [16,17].
Additionally, whole eggs contain the potent antioxidant,
lutein, which protects against numerous inflammatory
processes [18]. To our knowledge this is the first study
measuring inflammatory marker responses to a CRD uti-
lizing eggs as a source of dietary cholesterol and lutein.
We have previously shown that during an intervention
following a CRD, adult men consuming eggs presented a
significant increase in plasma HDL-C (P < 0.0001) com-
pared to those individuals who were consuming egg sub-
stitute [19]. The purpose of this study was to determine
whether the observed increases in HDL-C [19], plus the
fact that eggs are a good source of bioavailable lutein [17],
would affect the inflammatory response. Our initial
hypothesis was that the additional dietary cholesterol pro-
vided by eggs would not modify the beneficial effects of
the CRD.
Methods
Materials
Liquid whole eggs and cholesterol/fat-free eggs (placebo)
were purchased from the Vistar Corporation (Windsor,
CT). Aprotinin, sodium azide and phenylmethylsulfonyl
fluoride were obtained from Sigma Chemical (St. Louis,
MO). Human Cytokine, Human CVD Panel 1, and
Human CVD Panel 2 Lincoplex kits were obtained from
Linco (Linco Research, Inc, St.Charles, MI).
Subjects
Thirty-one healthy men aged 40–70 y, with a BMI
between 25 and 37 kg/m2 were recruited from the univer-
sity and the surrounding community[19]. All subjects
gave a written informed consent to participate and the
Committee on the Use of Human Subjects in Research of
the University of Connecticut approved the study proto-
col.
Study Design
The CRD was similar to those implemented in our previ-
ous studies[14], we conducted this study to determine the
effects of egg intake in conjunction with a CRD on the var-
iables for the classification of the metabolic syndrome
[19] and on body composition and inflammation mark-
ers presented in this manuscript. Briefly, subjects (n = 28)
were matched by age and BMI (body mass index) and
then randomly assigned, single blinded, to eggs (EGG, n
= 15) (640 mg cholesterol) or placebo (SUB, n = 13) (no
added cholesterol) for twelve weeks. Both products were
equal in consistency and color. All subjects attended a
group meeting before the intervention with registered die-
ticians where detailed instructions on keeping diet records
and following a CRD similar to those used in our previous
studies [14,20] were discussed. This was a free living food
study and no food was provided to subjects. The diet was
designed to restrict carbohydrates (~10% of total calories)
so that ketones are produced. Subjects were alsoNutrition & Metabolism 2008, 5:6 http://www.nutritionandmetabolism.com/content/5/1/6
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instructed to abstain from consuming eggs (other than
those provided by the study) during the whole interven-
tion. To monitor compliance to the ketogenic diet, sub-
jects used Ketostix reagent strips to assess ketonuria
nightly and returned their empty egg containers weekly.
Subjects were asked to maintain their habitual level of
exercise throughout the intervention. One week prior to
the start of the study, subjects completed a 3 day food
record to assess habitual food intake. Blood samples,
DEXA, food records and anthropometrics were collected
at baseline and week 12.
Blood collection
After an overnight fast, blood was collected into EDTA
from an antecubital vein. Plasma was separated by centrif-
ugation at 2000 × g; 20 min, and aprotinin (0.5 mL/100
mL), sodium azide (0.1 mL/100 mL), and phenylmethyl-
sulfonyl fluoride (0.1 mL/100 mL) were added for preser-
vation. Plasma was stored in individual aliquots at -80°C
for analysis of cytokines.
Plasma lipids, lutein, and insulin
Plasma triglycerides and total cholesterol were measured
by enzymatic analysis and HDL-cholesterol by measuring
cholesterol in the supernatant following precipitation of
the apo B containing lipoproteins as previously reported
[16]. LDL-C was estimated by the Friedwald equation
[21]. Plasma lutein was measured using Waters' HPLC sys-
tem [22] and detection was measured at 450 nm. Insulin
was measured with multiplex assay kit based on the
Luminex × MAP technology (Linco Research, Inc, St.
Charles, MI).
Body Weight and DEXA
Weight was measured to the closest 0.25 kg and height to
the closest 1 cm on a portable stadiometer/scale. Body
mass and body composition were measured in the morn-
ing after an overnight fast. Body mass was recorded to the
nearest 100 g on a calibrated digital scale with subjects
wearing only underwear. Whole body and regional body
composition was assessed using a state-of-the-art fan-
beam dual-energy X-ray absorptiometry (Prodigy™, Lunar
Corporation, Madison, WI). Analyses were performed by
the same blinded technician.
Fasting Adiponectin, sVCAM-1 and sICAM-1
From fasting plasma, VCAM-1, ICAM-1, and adiponectin
were measured in duplicate in the same assay using the
Human CVD Panel 1 Lincoplex kit. Samples were diluted
1:100 and simultaneously quantified by using Antibody-
Immobilized beads and Luminex × MAP technology. All
assays were carried out in the same day to decrease varia-
bility. The CV was between 2–6%. The sensitivity for
VCAM-1, ICAM-1, and adiponectin were 16.0 pg/ml, 9.0
pg/ml, and 56.0 pg/ml, respectively.
Fasting TNF-α, IL-8, and MCP-1
Plasma TNF-α, IL-8, and MCP-1 concentrations were
measured in duplicate in the same assay from a fasting
sample using the Human Cytokine Lincoplex kit, which is
a multiplex assay kit based on the Luminex × MAP tech-
nology (Linco Research, Inc, St. Charles, MI)[23]. This
method uses Antibody-Immobilized beads for simultane-
ous quantification of TNF-α, IL-8, and MCP-1. All assays
were carried out in the same day to decrease variability.
The CV was between 3–6%. The sensitivity for this assay
was 0.66 pg/ml, 1.12 pg/ml, and 1.29 pg/ml, respectively.
Fasting CRP
CRP concentration was measured in duplicate from fast-
ing plasma with a 1:2000 dilution using the Human CVD
Panel 2 (acute-phase proteins) Lincoplex kit. Antibody-
Immobilized beads were analyzed using Luminex × MAP
technology. The sensitivity of this assay was 6.0 pg/ml.
Statistical Analysis
Data are presented as means ± SD. A two-way repeated
measures ANOVA was used to determine the effects on
each subject on all parameters. Each individual's response
to the intervention over time was considered as the
repeated measure and egg vs. egg substitute the between
subject factors. Pearson correlations were used when
appropriate and differences of P < 0.05 were considered
significant.
Results
Diet and Plasma Lipids
In spite of the ad libitum dietary intervention, caloric
intake decreased significantly for all subjects (n = 28)
from 10243 ± 4039 kJ at baseline to 7967.82 ± 2401 kJ at
week 12 (P < 0.05). There were significant changes in
macronutrient intake during the intervention. Carbohy-
drate intake decreased from 42% of total calories at base-
line to 17% at week 12 (P < 0.001). Protein intake
increased from 17.8% at baseline to 25.8% at week 12 (P
< 0.001). Fat intake increased from 39.6% of total energy
at baseline to 55.6% at week 12 (P < 0.001). These
changes were consistent among the 28 subjects irrespec-
tive of the dietary group. However, dietary cholesterol
increased from 319 ± 150 g/d at baseline to 827 ± 192 g/
d at week 12 (P < 0.001) for the EGG group while there
were no changes in dietary cholesterol for the SUB group.
Values were 354 ± 170 g/d at baseline and 277 ± 100 g/d
after 12 wk (P > 0.15). A more detailed description of the
diet has been previously reported [19]
There was a significant increase in HDL-C for subjects in
the EGG group after 12 wk of the intervention (P < 0.001)
from 47.6 ± 15,1 mg/dL to 57.1 ± 15.1 mg/dL while the
subjects in the SUB group did not change their HDL-C
(50.0 ± 9.1 mg/dL at baseline and 48.9 ± 8.8 mg/dL post-Nutrition & Metabolism 2008, 5:6 http://www.nutritionandmetabolism.com/content/5/1/6
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intervention). Further, 13 out of 15 subjects had an
increase in HDL-C in the EGG group while only 3 out of
13 subjects had an increase in the SUB group [19]. Plasma
triglycerides were decreased for all subjects by an average
of 45% (P < 0.0001). The combined values for triglycer-
ides were 120.2 ± 59.4 mg/dl at baseline and 73.4 ± 26.9
mg/dl after week 12. There were no changes in total cho-
lesterol observed in either group (193.3 ± 37.9 mg/dl at
baseline and 194.8 ± 40.7 mg/dl at week 12). Individual
responses for total cholesterol between baseline and 12
weeks are presented in Figure 1 for both the EGG and the
SUB groups. There was a great variation in the response to
diet going from + 42 mg/dL to -74 mg/dl changes in total
cholesterol between baseline and 12 wk. There were no
significant changes in LDL-C between baseline and post-
treatment (P > 0.05) for either group. Values were 117.8 ±
37.8 mg/dl at baseline and 132.9 ± 43.6 mg/dl after week
12.
Plasma and Dietary Lutein
Plasma lutein was only increased in the EGG group (P <
0.01) from 0.54 ± 0.24 μmol/L to 0.93 ± 0.42 μmol/L
while there were no changes in plasma lutein for the SUB
group (0.53 ± 0.29 μmol/L at baseline to 0.53 ± 0.35
μmol/L after 12 wk)
Anthropometrics and Insulin
Body weight and fat mass were decreased significantly for
both the EGG and SUB group after the intervention (P <
0.0001) (Table 1). Body weight decreased 6.7 kg and 5.9
kg for the EGG and SUB groups, respectively. Likewise per-
cent body fat and percent trunk fat were significantly
decreased for both groups after 12 wk (P < 0.0001).
Changes in plasma insulin between baseline and 12 wk
for the EGG and SUB groups are presented in Figure 2,
panel A. Individual changes for all subjects are presented
in Figure 2, Panel B. Changes in insulin went from an
increase of 51 pmol/L to a decrease of -114 pmol/L with a
mean change of -26 pmol/L.
Concentrations of insulin for subjects from the EGG (n = 15)  or the SUB (n = 13) groups at baseline and at week 12 Figure 2
Concentrations of insulin for subjects from the EGG 
(n = 15) or the SUB (n = 13) groups at baseline and at 
week 12. ** indicates significantly different from baseline 
(Panel A). Individual responses to insulin are indicated in 
Panel B for subjects from the EGG group (blue lines, n = 15) 
and the SUB group (red lines, n = 13). The pink line repre-
sents the mean for the group
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Changes in total cholesterol between baseline and post- treatment for subjects from the EGG group (blue lines, n =  15) and the SUB group (red lines, n = 13) Figure 1
Changes in total cholesterol between baseline and 
post-treatment for subjects from the EGG group 
(blue lines, n = 15) and the SUB group (red lines, n = 
13). The pink line represents the mean for the group.
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Table 1: Body weight and body composition as measured by 
DEXA at Baseline and following 6 and 12 weeks of a carbohydrate 
restricted diet with 3 eggs per day (EGG group) or the equivalent 
of egg substitute (SUB)1
Variable Body Weight (Kg) Total Body Fat (Kg) Trunk Fat (Kg)
EGG
Baseline 98.9 ± 15.3 30.2 ± 8.0 18.6 ± 5.5
12 Weeks 92.2 ± 12.7 25.4 ± 8.4 15.3 ± 5.7
SUB
Baseline 97.6 ± 19.9 31.6 ± 12.4 19.8 ± 7.8
12 Weeks 91.7 ± 15.7 27.0 ± 12.0 16.6 ± 7.4
Time Effect P < 0.0001 P < 0.0001 P < 0.0001
Diet Effect NS NS NS
Interaction NS NS NS
1Values are means ± standard deviation. EGG n = 15, SUB n = 13. Data 
were analyzed using repeated measures ANOVA.Nutrition & Metabolism 2008, 5:6 http://www.nutritionandmetabolism.com/content/5/1/6
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Adiponectin, CRP, VCAM-1, and ICAM-1
The fasting values of adiponectin, CRP, VCAM-1, ICAM-1,
are presented in Table 2. Adiponectin was significantly
increased (P < 0.01) for both groups, with a higher
increase in the EGG (15.3 g/L to 18.5 g/L) (P < 0.05). The
individual changes in adiponectin for all subjects (n = 28)
are presented in Figure 3. There was an increase in adi-
ponectin in 12 subjects from the EGG group from a total
of 15 while only 7 out of 13 subjects from the SUB group
presented an increase in adiponectin (Figure 3). CRP was
only decreased in the EGG group (P < 0.05) Values were
reduced from 5.95 mg/L to 4.33 mg/L while there was a
non-significant increase in the SUB group (Table 2). There
were no differences in ICAM-1 or VCAM-1 observed in
either group.
TNF-α, IL-8, and MCP-1
The fasting values of TNF-α, IL-8, and MCP-1 before and
after the intervention are presented in Table 3. MCP-1 was
significantly reduced (P < 0.05) for the SUB group after
the intervention, while no change was observed in the
EGG group (interaction effect, P < 0.05). There were no
changes in TNF-α or IL-8 observed in either group.
Discussion
In this study we are reporting for the first time that eggs
modulate the response of certain inflammatory cytokines
during a weight loss intervention using a CRD. Subjects
consuming the eggs presented a better response to adi-
ponectin and CRP, two major markers of inflammation
and of CHD risk. This effect could be due to the high con-
centration of lutein, a potent antioxidant present in the
egg yolk.
Adiponectin
There was a significant increase in adiponectin in both the
EGG and SUB groups, with a greater increase in adiponec-
tin observed in the EGG group. An anti-atherogenic adi-
pokine, adiponectin decreases adhesion molecule
expression that occurs after inflammation [24] and also
decreases TNF-α production by macrophages [25]. Reduc-
tions in weight and fat mass in obese individuals is often
accompanied by an increase in serum adiponectin [26],
accordingly, we observed a significant reduction in trunk
fat in this study following the intervention. Inflammatory
cytokines suppress adiponectin expression [27], so the
increase in adiponectin may also be directly related to
reduction in these inflammatory markers and because of
a selective decrease of CRP only by eggs, a higher increase
of adiponectin was observed for this group. Paraoxonase
is an antioxidant carried on HDL that protects against LDL
oxidation [28], and with inflammation, there is a reduc-
tion in paroxonase levels [29]. The increased HDL-C and
additional adiponectin observed in the EGG group may
have resulted in elevations of paraoxonase, which may
explain improvements in the inflammatory profile. Direct
administration of adiponectin stimulates fatty acid oxida-
tion in hepatic and muscle tissues, which leads to
decreased triglycerides [30]. Increased adiponectin levels
are associated with increased insulin sensitivity, decreased
triglycerides, and increased HDL-C [31]. Accordingly, we
found that the EGG group presented a significant increase
in plasma HDL-C in addition to higher levels of adiponec-
tin. Egg intake is associated with significant increases in
HDL-C and concentration of anti-atherogenic large HDL
particles[16,17]. Large HDL particles are correlated with
decreased CHD risk [17,32] because they can more effi-
ciently remove excess cholesterol by returning it to the
liver for excretion. It is postulated that adiponectin may
influence reverse cholesterol transport (RCT) by increas-
ing HDL production in the liver by promoting apoA-1
synthesis and the ABCA1 pathway [33]. Additionally,
accelerated RCT results in decreased secretion of ApoB-
100 containing lipoproteins [34], which is evidenced by
the reduction in triglycerides. Lipoprotein lipase (LPL)
catalyzes the hydrolysis of triglycerides from ApoB-100
containing particles. Several studies show that adiponec-
tin is highly correlated with LPL activity [35,36]. In addi-
Table 2: Fasting serum Adiponectin, CRP, VCAM-1, ICAM-1 at Baseline and following 12 weeks of a carbohydrate restricted diet with 
3 eggs per day (EGG group) or egg substitute (SUB).
Variable Adiponectin (mg/L) CRP (mg/L) VCAM-1 (mg/L) ICAM-1 (mg/L)
EGG
Baseline 15.8 ± 4.6a 5.9 ± 2.9b 1.13 ± 0.15 0.21 ± 0.05
12 Weeks 18.6 ± 3.8b 4.3 ± 3.7a 1.19 ± 0.13 0.21 ± 0.04
SUB
Baseline 15.8 ± 5.9a 8.6 ± 6.5bc 1.17 ± 0.26 0.23 ± 0.06
12 Weeks 16.4 ± 5.2a 12.2 ± 11.5c 1.14 ± 0.30 0.21 ± 0.07
Time Effect P < 0.01 NS NS NS
Diet Effect NS NS NS NS
Interaction P < 0.05 P < 0.05 NS NS
Values are means ± standard deviation. EGG n = 15, SUB n = 13. Data were analyzed using repeated measures ANOVA. Values in the same column 
with different superscript indicate significantly different at P < 0.05.Nutrition & Metabolism 2008, 5:6 http://www.nutritionandmetabolism.com/content/5/1/6
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tion, there were significant reductions in insulin for both
groups. Carbohydrate restriction improves insulin resist-
ance by lowering insulin levels and the disinhibition of
hormone sensitive lipase, promoting triacylglycerol
hydrolysis [13]. As a result, there is an increase in cellular
fatty acid uptake and oxidation [13]. The increase in fatty
acid oxidation decreases hepatic triglyceride production
and the synthesis and secretion of triglyceride-rich VLDL
particles. Taken together, these data suggest that interven-
tions which increase HDL may also be directly involved in
improving the inflammatory response and increasing
insulin sensitivity as demonstrated by the increased levels
of plasma adiponectin.
CRP
At week 12, CRP was reduced only in the EGG group.
Serum CRP is an important marker of vascular inflamma-
tion and can be used to predict atherosclerosis [7].
Reduced CRP levels are found after weight loss interven-
tions and are inversely correlated to adiponectin [37]. The
reduction in adipose tissue due to weight loss reduces the
number of pro-inflammatory cytokines (TNF-α, IL-8.)
secreted by monocytes, and the number of macrophages
and endothelial cells present in the adipocytes [7]. Macro-
phages and endothelial cells produce CRP, so the reduc-
tions in adipose tissue as well as a reduction of
carbohydrates work in parallel to mediate the reduction in
CRP. Previously, Tannock et al. [38], found that the addi-
tion of 4 whole eggs/day for 4 weeks was associated with
increased levels of CRP in lean, insulin sensitive individu-
als, however, there was no effect on CRP in obese or insu-
lin resistant individuals. The subjects in the current study
were obese individuals undergoing weight loss and we
found that additional dietary cholesterol lowered CRP
levels. In previous studies, diets high in monounsaturated
fatty acids and polyunsaturated fatty acids have been asso-
ciated with decreased serum CRP [39]. Additionally, eggs
contain the potent antioxidants lutein and xeazanthin,
which might play a role in the reduction of inflammation
observed in the EGG group. Both groups had significant
increases in dietary intake of lutein, but only the EGG
group experienced an increase in plasma. These findings
correspond with results from another study that found
increases in the size and number of HDL particles is asso-
ciated with increased plasma lutein [18]. We speculate
that the reduction of CRP in the EGG group may be the
result of increased HDL-C preventing CRP induced upreg-
ulation of inflammatory adhesion molecules, possibly
through enhanced paraoxonase activity from antioxidants
and fatty acids contained within the egg yolk, which can
break down oxidized lipids to counteract proinflamma-
tory effects.
TNF-α, IL-8, and MCP-1
TNF-α is an inflammatory cytokine that is secreted 7.5
times higher from the abdominal adipose tissue of obese
subjects than their lean counterparts [40]. A few experi-
mental studies show that weight loss through short-term
caloric restriction can reduce circulating levels of TNF-α
[14,41], however a reduction of fat mass does not always
signal a reduction in TNF-α [42,43]. We did not observe a
change in fasting TNF-α in either experimental group.
These discrepancies are likely the result of the duration
and method of weight loss. Further studies are needed to
understand the relationship between TNF-α and central
Table 3: Fasting serum TNF-α, IL-8 and MCP-1 concentrations at 
Baseline and following 6 and 12 weeks of a carbohydrate 
restricted diet with 3 eggs per day (EGG group) or placebo 
(SUB).
Variable TNF-α (ng/L) IL-8 (pg/L) MCP-1 (μg/L)
EGG
Baseline 1.5 ± 0.9 1.3 ± 0.7 199.0 ± 87.1a
12 Weeks 1.9 ± 0.9 1.3 ± 0.7 194.5 ± 111.7a
SUB
Baseline 2.0 ± 0.9 1.7 ± 0.8 224.2 ± 115.8a
12 Weeks 2.0 ± 0.9 1.6 ± 0.7 157.0 ± 72.0b
Time Effect NS NS P < 0.05
Diet Effect NS NS NS
Interaction NS NS P < 0.05
Values are means ± standard deviation. EGG n = 15, SUB n = 13. Data 
were analyzed using repeated measures ANOVA. Values in the same 
column with different superscripts are significantly different at P < 
0.05.
Changes in adiponectin between baseline and post treatment  for subjects from the EGG (panel A, n = 15) or the SUB  (panel B, n = 13) group Figure 3
Changes in adiponectin between baseline and post 
treatment for subjects from the EGG (panel A, n = 
15) or the SUB (panel B, n = 13) group. The red line 
represents the mean for the group.
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obesity. Additionally, IL-8 did not change after the inter-
vention either. Stimulated by oxidized low-density lipo-
protein, IL-8's released from macrophages plays a key role
in the development of atherosclerosis [44]. IL-8 allows
adhesion of monocytes to the endothelium [45], which
promotes the atherosclerotic process. TNF-α stimulates IL-
8 synthesis in the adipocytes [46], so the equivocal results
found for IL-8 production likely relates to the failure of
TNF-α levels to change after the intervention.
MCP-1 levels were significantly reduced for the SUB group
at week 12, while no change was observed for the EGG
group. MCP-1 is an inflammatory chemokine mostly pro-
duced by endothelial cells and macrophages. In visceral
adipose tissue, an elevation in MCP-1 is associated with
an increased ability to attract macrophages, which rein-
forces the inflammatory cycle [25]. In endothelial cells,
leptin secreted from adipose tissue enhances MCP-1 syn-
thesis [47]. At this point, it is not clear why the SUB group
had a greater reduction in MCP-1 compared to the EGG
group. However, the reduction of MCP-1 observed in
both groups, although not significant in the EGG group,
may be the result of decreased circulating leptin due to
weight loss in the current study. We have also observed
that subjects in both groups reduced levels of leptin fol-
lowing the CRD intervention (Ratliff and Fernandez,
unpublished observations).
VCAM-1 and ICAM-1
VCAM-1 and ICAM-1 levels did not change throughout
the intervention for either group. Circulating adhesion
molecules play an active role in the atherogenic process by
adhering circulating leukocytes into vessel walls. Proteol-
ysis of membrane bound molecules releases soluble forms
of VCAM-1 and ICAM-1 into the bloodstream, which can
serve as markers of endothelial inflammation [48,49].
Endothelial VCAM-1 and ICAM-1 are upregulated in
response to TNF-α [50]. In the current study, there was no
change in TNF-α observed in either group, which may
result in the unchanged serum VCAM-1 and ICAM-1 val-
ues. A previous study found that caloric restriction in con-
junction with exercise for one year lowered plasma
VCAM-1 and ICAM-1 in overweight women [51]. The
brief duration of the current study, gender, or the lack of
structured exercise might also explain why there was not a
reduction in cellular adhesion molecules for either group.
Conclusion
We conclude that daily intake of 3 eggs while following a
CRD results in a significant decrease in CRP and a more
pronounced increase in adiponectin, thus, improving the
inflammatory profile. These findings suggest a role of eggs
due to their cholesterol and antioxidant content in achiev-
ing maximum benefits with carbohydrate restricted diets
on certain inflammatory cytokines.
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